• integral component of membrane • 膜 • cytoplasmic vesicle lumen • 細胞膜 • integral component of plasma membrane • cell surface • lysosomal lumen • カベオラ • perinuclear region of cytoplasm • 脂質ラフト • リソソーム • エキソソーム • cytoplasmic vesicle • 細胞核 • external side of plasma membrane • 細胞外領域 • 細胞外空間
生物学的プロセス
• T cell apoptotic process • regulation of transcription, DNA-templated • 細胞間シグナル伝達 • endosomal lumen acidification • negative regulation of transcription by RNA polymerase II • retinal cell programmed cell death • transcription, DNA-templated • リポ多糖への反応 • positive regulation of neuron apoptotic process • positive regulation of endothelial cell apoptotic process • necroptotic signaling pathway • 免疫応答 • positive regulation of cell population proliferation • positive regulation of apoptotic process • positive regulation of I-kappaB kinase/NF-kappaB signaling • negative regulation of angiogenesis • regulation of extrinsic apoptotic signaling pathway via death domain receptors • cellular chloride ion homeostasis • response to growth factor • inflammatory cell apoptotic process • positive regulation of epidermal growth factor receptor signaling pathway • extrinsic apoptotic signaling pathway via death domain receptors • シグナル伝達 • extrinsic apoptotic signaling pathway • activation of cysteine-type endopeptidase activity involved in apoptotic process • ネクロトーシス(またはネクロプトーシス) • apoptotic signaling pathway • negative regulation of extrinsic apoptotic signaling pathway via death domain receptors • アポトーシス • release of sequestered calcium ion into cytosol by endoplasmic reticulum • regulation of signaling receptor activity • サイトカイン媒介シグナル伝達経路
^Yonehara S, Ishii A, Yonehara M (1989). “A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.”. J Exp Med169 (5): 1747-56. doi:10.1084/jem.169.5.1747. PMC 2189304. PMID (2469768). http://jem.rupress.org/content/169/5/1747.abstract.
^“Death and decoy receptors and p53-mediated apoptosis”. Leukemia14 (8): 1509–1513. (2000). doi:10.1038/sj.leu.2401865. PMID (10942251).
^“Cytotoxic T cells”. J. Invest. Dermatol.126 (1): 32–41. (2006). doi:10.1038/sj.jid.5700001. PMID (16417215).
^“Tumor counterattack: fact or fiction?”. Cancer Immunol. Immunother.54 (11): 1127–1136. (2005). doi:10.1007/s00262-005-0680-7. PMID (15889255).
^ abcd“Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy”. J. Biol. Chem.280 (12): 11641–7. (March 2005). doi:10.1074/jbc.M411781200. PMID (15659383).
^ abc“Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes”. Cell114 (2): 181–90. (July 2003). doi:10.1016/s0092-8674(03)00521-x. PMID (12887920).
^“CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway”. EMBO J.19 (19): 5123–34. (October 2000). doi:10.1093/emboj/19.19.5123. PMC 302100. PMID (11013215). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC302100/.
^ abc“Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178)”. FEBS Lett.519 (1-3): 50–8. (May 2002). doi:10.1016/s0014-5793(02)02709-6. PMID (12023017).
^ ab“Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor”. FEBS Lett.509 (2): 255–62. (December 2001). doi:10.1016/s0014-5793(01)03174-x. PMID (11741599).
^“Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain”. FEBS Lett.373 (3): 265–8. (October 1995). doi:10.1016/0014-5793(95)01051-f. PMID (7589480).
^“Characterization of Fas (Apo-1, CD95)-Fas ligand interaction”. J. Biol. Chem.272 (30): 18827–33. (July 1997). doi:10.1074/jbc.272.30.18827. PMID (9228058).
^“A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis”. J. Biol. Chem.274 (20): 13733–6. (May 1999). doi:10.1074/jbc.274.20.13733. PMID (10318773).
^“Modulation of dendritic cell differentiation and maturation by decoy receptor 3”. J. Immunol.168 (10): 4846–53. (May 2002). doi:10.4049/jimmunol.168.10.4846. PMID (11994433).
^“Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer”. Nature396 (6712): 699–703. (December 1998). doi:10.1038/25387. PMID (9872321).
関連資料
“Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses”. Brain Res. Brain Res. Rev.44 (1): 65–81. (January 2004). doi:10.1016/j.brainresrev.2003.08.007. PMID (14739003).
“HIV/SIV escape from immune surveillance: focus on Nef”. Curr. HIV Res.2 (2): 141–51. (2004). doi:10.2174/1570162043484924. PMID (15078178).
外部リンク
GeneReviews/NCBI/NIH/UW entry on Autoimmune Lymphoproliferative Syndrome